amide/breast neoplasms

BACKGROUND OF THE INVENTION Type 2 diabetes, also referred to as non-insulin dependent diabetes mellitus (NIDDM), afflicts between 80 and 90% of all diabetic patients in developed countries. In the United States alone, approximately 15 million people, and more than 100 million worldwide, are

CROSS REFERENCES TO RELATED APPLICATIONS This application is a 371 of International Patent Application No. PCT/JP14/065181, filed on Jun. 9, 2014, and claims priority to Japanese Patent Application No. 2013-122180, filed on Jun. 10, 2013. TECHNICAL FIELD The present invention relates to a bicyclic

DESCRIPTION OF THE TEXT FILE SUBMITTED ELECTRONICALLY The contents of the text file submitted electronically herewith are incorporated herein by reference in their entirety: A computer readable format copy of the Sequence Listing (filename: DECP.sub.--018.sub.--03US_SeqList.txt, date recorded: Jul.

TECHNICAL FIELD This invention relates to organic compounds having pharmacological activity, to compositions containing the compounds, to medical methods of treatment employing the compounds, and to chemical processes and intermediates for their production. More particularly, the present invention

BACKGROUND OF THE INVENTION In the United States, breast cancer is the most common cancer diagnosed in women and is the second leading cause of death in women after lung cancer. It is estimated that 212,920 new cases of invasive breast cancer will be detected among women in the United States in the

FIELD OF THE INVENTION This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein. GENERAL BACKGROUND The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a national stage filing under 35 U.S.C. 371 of PCT application PCT/GB01/00245, filed Jan. 24, 2001, which claims priority to European Application No. 00400228.3, filed Jan. 28, 2000, the specifications of each of which are incorporated by

BACKGROUND OF THE INVENTION 1. Field of Invention The present invention relates to a radioactive mixture and a manufacturing method thereof, especially to a radioactive mixture and a manufacturing method thereof applied to liver cancer treatment. 2. Description of Related Art Liver is the largest

This application is the National Phase filing of International Patent Application No. PCT/JP01/10079, filed 19 Nov. 2001. TECHNICAL FIELD OF THE INVENTION The present invention relates to a pharmaceutical agent, particularly, a novel imidazole derivative having a steroid C.sub.17,20 -lyase